OTC market may have to accept regulatory change post-Enron

The over-the-counter (OTC) derivatives industry may have to accept changes to regulation following the collapse of Enron, James Newsome, chairman of the US Commodity Futures Trading Commission (CFTC) warned on June 18.

While he said most Enron-related issues are focused on corporate governance and accounting rules, he added that changes in rules covering OTC derivatives are possible. But Newsome cautioned that regulators have to wait for the “big picture” surrounding Enron before advocating

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options


Want to know what’s included in our free membership? Click here

This address will be used to create your account

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here